KBW Raises MCHB Target as Options Sentiment Shifts Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
MCHB heads into August with a fresh analyst upgrade, a notable pivot in options sentiment, and a stock that managed a 5.4% weekly gain even as it dipped on Tuesday — a setup worth unpacking for a small regional bank trading near book value.
The clearest story this week is on the Street. Keefe, Bruyette & Woods raised its price target on MCHB to $17.50 from $16.00 on August 5, keeping a Market Perform rating — a modest but meaningful lift that puts the consensus mean target at roughly $17.33 against a close of $16.69. That implies around 4% upside to the average target, thin but directionally positive. Raymond James initiated at Outperform with a $17.00 target back in May, and Cantor Fitzgerald began coverage at Overweight with the same figure in April. The coverage build-out is notable for a Nasdaq-listed community bank of this size. Overall, the Street has been warming up: three of the five recorded analyst actions have been initiations or target raises, and none has gone negative on the rating. Note that Benzinga's bull/bear case text in the dataset references HomeStreet Inc. and appears to be misattributed — those cases have been set aside.
Options positioning has shifted sharply toward the bullish end of the recent range. The put/call ratio has dropped to 0.65, well below the 20-day mean of 0.49 — though the notable feature is the trajectory: as recently as early July the PCR was running above 1.0, meaning more puts than calls were outstanding. The rotation from above-1.0 to 0.65 over the past four weeks reflects a meaningful change in how options traders are leaning. The z-score of 0.49 places the current reading only half a standard deviation above the recent mean, so the reading is not extreme — but the direction of travel is clearly from defensive toward constructive.
Short interest is low and unlikely to drive the narrative here. At 1.6% of free float, MCHB is not a heavily shorted name. The position has crept up about 12% over the past month in share terms, yet in absolute terms it remains modest — around 3.5 million shares. Borrowing costs have nudged higher, now at 1.14%, up roughly 46% over the past month, but the absolute level is still benign. Borrow availability is ample at 452%, meaning there are more than four shares available to borrow for every one already lent out, well off the 52-week tightest reading of 15.8%. Nothing in the lending market suggests squeeze pressure or a crowded short.
Ownership structure is worth a note given its unusual concentration. Ford Financial Fund holds 74% of shares, a controlling stake that has been static for at least the past year. Beyond that anchor, the Downer family names — Edward and Douglas — together account for roughly 3.6% of shares, with a recent internal transfer visible in the filing history (Edward reduced by 1.1 million shares, Douglas added the same amount in May). Institutional coverage is thin but growing, with BlackRock, Vanguard Capital Management, State Street, and Geode all on the register and the latter two adding incrementally as of June 30. The factor score picture rounds out the view: dividend score ranks in the 81st percentile, reflecting the stock's income characteristics. Short score sits at 58 and has been edging higher over the past two weeks, while momentum and value factors are both modestly positive relative to sector peers.
Valuation has been drifting upward. The price-to-book multiple has climbed to around 1.44x, up from roughly 1.37x a month ago, and the P/E has moved to just under 15x. Neither is stretched for a regional bank with a growing analyst following, but the re-rating means less of a valuation cushion than was available in the spring. The next earnings event is scheduled for late October, and the most recent quarterly print produced a 4.8% one-day move — the prior quarter delivered 1.8%. With KBW's fresh target raise and a PCR that has rotated meaningfully toward calls, the dynamic to watch heading into that October report is whether the Street's cautiously constructive tone holds as NIM trends come into focus.
Stocks in this article
See the live data behind this article on ORTEX.
Open MCHB on ORTEX →How this article was generated
- Generated
- 5 Aug 2026, 20:27
- Data as of
- 5 Aug 2026, 20:20
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.